Literature DB >> 26599057

Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia.

Erica M Weekman, Donna M Wilcock.   

Abstract

The neurovascular unit, which consists of astrocytic end-feet, neurons, pericytes, and endothelial cells, plays a key role in maintaining brain homeostasis by forming the blood-brain barrier and carefully controlling local cerebral blood flow. When the blood-brain barrier is disrupted, blood components can leak into the brain, damage the surrounding tissue and lead to cognitive impairment. This disruption in the blood-brain barrier and subsequent impairment in cognition are common after stroke and during cerebral amyloid angiopathy and Alzheimer's disease. Matrix metalloproteinases are proteases that degrade the extracellular matrix as well as tight junctions between endothelial cells and have been implicated in blood-brain barrier breakdown in neurodegenerative diseases. This review will focus on the roles of MMP2 and MMP9 in dementia, primarily post-stroke events that lead to dementia, cerebral amyloid angiopathy, and Alzheimer's disease.

Entities:  

Keywords:  Alzheimer’s disease,; cerebral amyloid angiopathy; hemorrhagic transformation; matrix metalloproteinases; stroke; vascular cognitive impairment

Mesh:

Substances:

Year:  2016        PMID: 26599057     DOI: 10.3233/JAD-150759

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

1.  Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.

Authors:  Jing Wang; Xialin Chen; Weirong Bai; Zhenzhong Wang; Wei Xiao; Jingbo Zhu
Journal:  Neurochem Res       Date:  2021-05-14       Impact factor: 3.996

Review 2.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

3.  Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the Rho/ROCK signaling pathway.

Authors:  Fangbin Chen; Zhiyang Liu; Wei Peng; Zhiqin Gao; Hui Ouyang; Tongjun Yan; Songbai Ding; Zhankui Cai; Bin Zhao; Longjin Mao; Zhiyong Cao
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

Review 4.  An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia.

Authors:  Brittani R Price; Christopher M Norris; Pradoldej Sompol; Donna M Wilcock
Journal:  J Neurochem       Date:  2018-01-22       Impact factor: 5.372

5.  A single low dose of hydrocortisone enhances cognitive functioning in HIV-infected women.

Authors:  Leah H Rubin; K Luan Phan; Sheila M Keating; Pauline M Maki
Journal:  AIDS       Date:  2018-09-10       Impact factor: 4.177

Review 6.  Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Authors:  Franciska Erdő; László Denes; Elizabeth de Lange
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-11       Impact factor: 6.200

7.  Pericytes as Inducers of Rapid, Matrix Metalloproteinase-9-Dependent Capillary Damage during Ischemia.

Authors:  Robert G Underly; Manuel Levy; David A Hartmann; Roger I Grant; Ashley N Watson; Andy Y Shih
Journal:  J Neurosci       Date:  2017-01-04       Impact factor: 6.167

8.  Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma.

Authors:  Rachel C Knopp; Ammar Jastaniah; Oleksii Dubrovskyi; Irina Gaisina; Leon Tai; Gregory R J Thatcher
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-02

Review 9.  Effects of Thrombin on the Neurovascular Unit in Cerebral Ischemia.

Authors:  Hui Cao; Sai Wang Seto; Deep Jyoti Bhuyan; Hoi Huen Chan; Wenting Song
Journal:  Cell Mol Neurobiol       Date:  2021-01-03       Impact factor: 5.046

Review 10.  Intracranial Arterial Dolichoectasia.

Authors:  Victor J Del Brutto; Jorge G Ortiz; José Biller
Journal:  Front Neurol       Date:  2017-07-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.